The influence of FCGR2A and FCGR3A polymorphisms on the survival of patients with recurrent or metastatic squamous cell head and neck cancer treated with cetuximab.
| Image |  |
|---|---|
| Description | scientific article published on 18 July 2017 |
| Author/s |
author: Teresa Magnes Alexander Egle |
| Publication date | July 18, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |